Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus

2008 ◽  
Vol 4 (7) ◽  
pp. 352-353 ◽  
Author(s):  
Hai Feng Pan ◽  
Dong Qing Ye ◽  
Xiang Pei Li
1999 ◽  
Vol 42 (8) ◽  
pp. 1644-1648 ◽  
Author(s):  
Mitsuteru Akahoshi ◽  
Hitoshi Nakashima ◽  
Yosuke Tanaka ◽  
Tsutomu Kohsaka ◽  
Shuji Nagano ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Tomohiro Koga ◽  
Kunihiro Ichinose ◽  
Atsushi Kawakami ◽  
George C. Tsokos

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune cell abnormalities which lead to the production of autoantibodies and the deposition of immune complexes. Interleukin (IL)-17-producing cells play an important role in the pathogenesis of the disease, making them an attractive therapeutic target. Studies in lupus-prone mice and of ex vivo cells from patients with SLE humans have shown that IL-17 represents a promising therapeutic target. Here we review molecular mechanisms involved in IL-17 production and Th17 cell differentiation and function and an update on the role of IL-17 in autoimmune diseases and the expected usefulness for targeting IL-17 therapeutically.


2011 ◽  
Vol 39 (1) ◽  
pp. 771-774 ◽  
Author(s):  
Feng-Lai Yuan ◽  
Xia Li ◽  
Wei-Guo Lu ◽  
Yi-Qing Zhao ◽  
Cheng-Wan Li ◽  
...  

2010 ◽  
Vol 41 (3) ◽  
pp. 221-225 ◽  
Author(s):  
Rui-Xue Leng ◽  
Hai-Feng Pan ◽  
Gui-Mei Chen ◽  
Chao Wang ◽  
Wei-Zi Qin ◽  
...  

Rheumatology ◽  
2009 ◽  
Vol 48 (12) ◽  
pp. 1491-1497 ◽  
Author(s):  
B. C.-H. Kwan ◽  
L.-S. Tam ◽  
K.-B. Lai ◽  
F. M.-M. Lai ◽  
E. K.-M. Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document